Ultragenyx Pharmaceutical Inc. - RARE

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Oct 19, 2026 Chief Financial Officer S D 7,066.0 15.27 107,897.82 89,229.0 View
Sep 15, 2026 SVP, Chief Accounting Officer S D 1,283.0 13.57 17,410.31 67,863.0 View
Sep 08, 2026 SVP, Chief Accounting Officer S D 161.0 13.99 2,252.39 69,146.0 View
Aug 04, 2026 EVP and Chief Legal Officer S D 1,900.0 24.92 47,348.0 92,562.0 View
Aug 04, 2026 Chief Financial Officer S D 4,696.0 24.92 117,024.32 96,295.0 View
Jul 06, 2026 Chief Financial Officer S D 4,698.0 33.13 155,644.74 100,991.0 View
Jun 15, 2026 — S D 2,000.0 25.05 50,100.0 21,095.0 View
Jun 15, 2026 EVP and Chief Legal Officer S D 1,899.0 24.62 46,753.38 94,462.0 View
Jun 01, 2026 Chief Financial Officer S D 4,653.0 23.77 110,601.81 105,689.0 View